The Filing Desk

Cerus vs SI-BONE

Cerus CERS · SI-BONE SIBN · Health Care Equipment

Cerus reported revenue of $234 million in fiscal 2025, 1.2 times SI-BONE's $201 million in fiscal 2025. Cerus' revenue grew 16.1% in its latest year, and SI-BONE's grew 20.2%. Cerus had an operating margin of -3.7%, against -11.1% at SI-BONE. Free cash flow was $1 million at Cerus and −$9 million at SI-BONE.

Side by side

CerusSI-BONE
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$234M$201M
Revenue growth16.1%20.2%
Revenue growth a year, last 5 years15.4%22.3%
Gross margin—79.6%
Operating margin−3.7%−11.1%
Net margin−6.7%−9.4%
Free cash flow$1M−$9M
Free cash flow margin0.5%−4.5%
Return on capital—−26.3%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count3.3%3.6%
Last close$1.99$23.44
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CerusSI-BONE
Operating margin
Percent of revenue
CerusSI-BONE
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CerusSI-BONE

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cerus and SI-BONE pages.